Thursday, October 20, 2022: Life Sciences

The Food and Drug Administration (FDA) authorized a booster dose of Novavax’s COVID-19 vaccine. The booster was authorized for adults ages 18 and older who can’t take an mRNA vaccine or don’t have access to one, as well as for adults who would otherwise not receive a...

Thursday, October 20, 2022: Life Sciences

An FDA advisory panel recommended to pull Makena, a pre-term birth prevention drug, off the market. The panel said that the drug has not shown to be effective and exposes women to “serious risk.” The decision came after years of tension between the company, the...

Thursday, October 20, 2022: Payers

Surgeon General Vivek Murthy released guidance detailing how long hours, lack of autonomy, low pay, and other elements of a toxic workplace can impact the health and organizational performance of workers. The guidance supports the Surgeon General’s Advisory on...